TFGT
TXMD icon

TS Financial Group (TSFG)’s TherapeuticsMD TXMD Stock Holding History

TS Financial Group (TSFG)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64
Closed – – 899
2025
Q2 		$0 Hold
64
– – ﹤0.01% 878
2025
Q1 		$0 Hold
64
– – ﹤0.01% 861
2024
Q4 		$0 Hold
64
– – ﹤0.01% 823
2024
Q3 		$0 Hold
64
– – ﹤0.01% 844
2024
Q2 		$0 Buy
+64
New +$129 ﹤0.01% 805
2019
Q1 		– Hold
0
– – – 740

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TS Financial Group (TSFG)'s TXMD Position: Q3 2025 in Review

TS Financial Group (TSFG) sold out of TherapeuticsMD (TXMD) in Q3 2025, closing a stake of 64 shares.

TS Financial Group (TSFG) first reported a position in TXMD in Q2 2024 and held it in 5 quarters. The position peaked at $0 in Q2 2025. 46 funds tracked by Wall St. Rank hold TXMD as of Q3 2025.

  • TS Financial Group (TSFG) reported no remaining TherapeuticsMD position as of Q3 2025 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 64 TherapeuticsMD shares in Q3 2025.
  • TS Financial Group (TSFG) first reported a position in TherapeuticsMD in Q2 2024 and held it in 5 quarters.
  • TS Financial Group (TSFG)'s TherapeuticsMD position peaked at $0 in Q2 2025.
  • 46 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q3 2025, filed 4 Nov 2025.